What makes a great clinical trial in physiotherapy?


Journal

Physiotherapy theory and practice
ISSN: 1532-5040
Titre abrégé: Physiother Theory Pract
Pays: England
ID NLM: 9015520

Informations de publication

Date de publication:
Oct 2022
Historique:
pubmed: 5 1 2021
medline: 28 9 2022
entrez: 4 1 2021
Statut: ppublish

Résumé

To identify common characteristics of landmark physiotherapy clinical trials. The Physiotherapy Evidence Database (PEDro) top five trials were compared to 91 physiotherapy trials published in top medical journals and 99 trials randomly selected from PEDro on the following characteristics: PEDro score, sample size, number of trial sites, use of prospective registration, positive or negative trial, citations, citations in guidelines, Altmetric score, impact factor, publications and citations of first and last author, and PEDro codes (sub-discipline, topic, problem, therapy, and body part). Trials were published from 2014 to 2019. One-way independent ANOVA and Chi-squared test evaluated between-group differences. Compared to a random sample of physiotherapy trials, the PEDro top five trials and trials in top medical journals have higher PEDro scores, larger sample sizes, more study sites, more citations (including in guidelines), higher Altmetric scores, more likely to be prospectively registered, less likely to be positive trials, and have first and last authors with more citations and publications. The problem was the only PEDro code was distributed differently across the trial groups. The PEDro top five trials and physiotherapy trials published in the top medical journals have characteristics that may inform the design, conduct, and reporting of future physiotherapy trials.

Identifiants

pubmed: 33390086
doi: 10.1080/09593985.2020.1870252
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1478-1487

Auteurs

Joshua R Zadro (JR)

School of Public Health, Faculty of Medicine and Health, Institute for Musculoskeletal Health, University of Sydney and Sydney Local Health District, Camperdown, Australia.

Anita B Amorim (AB)

School of Public Health, Faculty of Medicine and Health, Institute for Musculoskeletal Health, University of Sydney and Sydney Local Health District, Camperdown, Australia.
School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Lidcombe, Australia.

Giovanni Ferreira (G)

School of Public Health, Faculty of Medicine and Health, Institute for Musculoskeletal Health, University of Sydney and Sydney Local Health District, Camperdown, Australia.

Xiaocong Hu (X)

School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Rosa E Becerra (RE)

School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Broti S Reza (BS)

School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Samar Khan (S)

School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Anne M Moseley (AM)

School of Public Health, Faculty of Medicine and Health, Institute for Musculoskeletal Health, University of Sydney and Sydney Local Health District, Camperdown, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH